As the U.S. continues to battle a devastating opioid epidemic, access to comprehensive and flexible care has become more important than ever. Virtual medication-assisted treatment (MAT) provider PursueCare is responding to this need by launching Hybrid Medication-Assisted Treatment clinics in Allentown, Pennsylvania, and soon in Voorhees, New Jersey. These new facilities represent a major step forward in bridging the gap between emergency care and long-term recovery, offering both in-person and virtual services under one coordinated model.
Headquartered in Middletown, Connecticut, PursueCare is known for its innovative virtual care platform. Now, it’s embracing Hybrid Medication-Assisted Treatment to reach even more individuals struggling with substance use disorder (SUD). The company’s new clinic in Allentown is fully operational and licensed by the Pennsylvania Department of Drug and Alcohol Programs. It provides a full spectrum of outpatient services, including access to buprenorphine for opioid use disorder (OUD), and it is conveniently located next to 17th Street Hospital, part of the Lehigh Valley Health Network.
Breaking Down Barriers with Hybrid Care
What makes PursueCare’s model so powerful is its commitment to Hybrid Medication-Assisted Treatment—blending the convenience of virtual visits with the personal connection of face-to-face care. For patients who lack access to technology, the clinics offer mobile devices that can be used for virtual appointments either on-site or at home. This flexibility ensures that no one is left behind due to transportation issues, digital barriers, or stigma.
In Voorhees, New Jersey, PursueCare is preparing to open a second hybrid location, expanding its reach into the Philadelphia suburbs. The need is urgent: recent CDC data suggests that overdose deaths are expected to exceed 104,000 annually, with many caused by synthetic opioids like fentanyl. PursueCare’s expansion aims to combat these rising numbers by delivering care faster and more efficiently through Hybrid Medication-Assisted Treatment.
Partnerships That Strengthen Community Support
The Allentown clinic is physically connected to 17th Street Hospital via a skybridge, making transitions between emergency and outpatient services seamless. PursueCare is also forming collaborations with Valley Health Partners, a trusted network of community health centers. These partnerships are designed to improve the continuum of care—a major weakness in current treatment systems.
“The continuum of care between the ‘front doors’ for people with substance use disorder and the effective outpatient care they need is broken,” said PursueCare CEO Nick Mercadente. “We are working to fix this.”
This focus on continuity is at the heart of Hybrid Medication-Assisted Treatment. By coordinating services with hospitals, behavioral health centers, and community organizations, PursueCare ensures that patients receive support at every stage of their recovery journey.
A Platform That Reaches Millions
Since 2019, PursueCare has grown into a multi-state provider, currently operating in 12 states and serving patients with SUD, alcohol and tobacco addiction, and mental health concerns like depression. Their platform offers 24/7 access, same-day referrals, and services tailored to individual needs.
Importantly, PursueCare accepts a broad range of payment options, including Medicaid, Medicare, and major managed care plans that reach an estimated 38 million people. This makes Hybrid Medication-Assisted Treatment available to a wide population, including underserved and marginalized communities that often face the greatest treatment barriers.
Building Healthier Communities Together
The decision to open physical clinics doesn’t mark a shift away from virtual care—it enhances it. PursueCare’s model is based on meeting people where they are, and in many cases, that means offering a combination of in-person interaction and virtual check-ins.
“The COVID-19 pandemic exacerbated the existing addiction and overdose epidemic,” said Veronica Gonzalez, CEO of Valley Health Partners. “The need for both substance use disorder and mental health resources in our community continues to rise. We are proudly partnering with organizations, including PursueCare, to remove barriers, meet patients where they are, and build stronger and healthier communities.”
Through Hybrid Medication-Assisted Treatment, PursueCare not only offers a more adaptable approach but also reinforces its belief that recovery should be accessible, stigma-free, and fully integrated into local health systems.
Looking Ahead: Expansion on the Horizon
PursueCare is not stopping with Pennsylvania and New Jersey. The company has plans to bring its Hybrid Medication-Assisted Treatment model to additional states, including Delaware, Kansas, Maryland, and New York. These expansions are part of a larger goal to build a national network of integrated, hybrid SUD care, rooted in collaboration with hospitals, health systems, and behavioral health partners.
By creating localized solutions while maintaining the scalability of virtual care, PursueCare is positioning itself as a leader in the next generation of addiction and mental health treatment.
Final Thoughts
With its expansion into hybrid clinics, PursueCare is addressing one of the most critical gaps in behavioral health: the lack of coordinated, accessible care for those struggling with substance use. By blending in-person services with advanced telehealth capabilities, Hybrid Medication-Assisted Treatment offers the flexibility, reach, and compassion that today’s patients need.
As overdose rates continue to rise, the healthcare system must evolve. PursueCare’s hybrid approach offers a replicable model that could change the face of recovery care in America—connecting more people to treatment, faster, and with better outcomes.
.){kind=link}